Φορτώνει......
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
BACKGROUND: There is limited information on treatment strategies and monitoring strategies for late antibody-mediated rejection (ABMR) after kidney transplantation. METHODS: In this observational and nonrandomized study, we compared 78 patients diagnosed with late ABMR (>3 months after transplant...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Transplant Direct |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828696/ https://ncbi.nlm.nih.gov/pubmed/29536028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000746 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|